Clinical Trial Update: Dextenza in the Post-op Management of Vitreoretinal Surgeries [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Dextenza for post-operative management of vitreoretinal surgeries, focusing on ocular inflammation and pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation
• Postoperative Inflammation
• Postoperative Pain
• Vitreoretinal Diseases

Drugs mentioned

• Dextenza (Dexamethasone)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Vitreoretinal Surgery, Ocular Inflammation | Phase 4 | Status: RECRUITING